Cargando…
Liraglutide and obesity: a review of the data so far
The prevalence of obesity worldwide has nearly doubled since 1980 with current estimates of 2.1 billion in 2013. Overweight and obesity lead to numerous adverse conditions including type 2 diabetes, cardiovascular disease, stroke, and certain cancers. The worldwide spread of obesity and associated c...
Autor principal: | Ladenheim, Ellen E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386791/ https://www.ncbi.nlm.nih.gov/pubmed/25848222 http://dx.doi.org/10.2147/DDDT.S58459 |
Ejemplares similares
-
Obesity genes: so close and yet so far...
por: Pomp, Daniel, et al.
Publicado: (2008) -
Laquinimod in the treatment of multiple sclerosis: a review of the data so far
por: Thöne, Jan, et al.
Publicado: (2016) -
Reslizumab in the management of poorly controlled asthma: the data so far
por: Maselli, Diego Jose, et al.
Publicado: (2016) -
Dupilumab in the management of moderate-to-severe asthma: the data so far
por: Barranco, Pilar, et al.
Publicado: (2017) -
Human Carcinogens So Far Identified
por: Tomatis, Lorenzo, et al.
Publicado: (1989)